[Use of recombinant factor VIIa to reduce transfusional load in hemorrhaging patients after surgery for malignant tumors].

Often expanded surgical interventions in patients with malignant tumors are accompanied by huge bleeding and require transfusion of big mass of medications prepared from donor blood that may develop different complications. It is showed that with the aim of treatment of hemorrhagic complications the use of recombination factor VIIa allows reducing the surgical blood loss, as well as diminishing hemotransfusional load after surgery especially in patients with malignancies of urogenital system and malignant tumors of the colon and lung.

[Cryosurgical treatment of basal cell carcinoma of the skin].

Cryosurgical method was used for the treatment of 102 patients with basal cell carcinoma of the skin. A portable cryosurgical apparatus with a set of applicators was used. Liquid nitrogen was used as the cold agent.